Claritas overview
Stories about Claritas
Claritas Genomics picks up $15 mln
Cambridge, Massachusetts-based Claritas Genomics, a provider of genetic diagnostic testing solutions, has raised $15 million in Series B funding. WuXi NextCODE Genomics led the round with participation from Boston Children's Hospital, Cerner Corporation and Cincinnati Children's Hospital Medical Center.
Claritas funds managed
Closed funds: 3
| Fund | Fund size | Close date | Strategy |
|---|---|---|---|
Fund size  ---------- | Close date- | Strategy ----------- | |
Fund size ----- | Close date- | Strategy ---------- | |
Fund size ---------- | Close date- | Strategy -------- | |
Stories that mention Claritas
SAP and Carlyle on harnessing the potential of digital
Private equity firms are leveraging tech advances to drive transformative value creation, say Sean Epstein, SVP and head of private equity at SAP, and Georgette Kiser, operating executive at the Carlyle Group.
Carlyle buys Thomas Scientific
The Carlyle Group has acquired a majority stake in Swedesboro, New Jersey-based Thomas Scientific, a provider of laboratory supplies and equipment for the scientific and research community. No financial terms were disclosed. When the transaction closes, Rob Patterson, a fourth-generation family owner, will retain a significant ownership stake in the company while Charles Simmons will continue as president and CEO.
Fund briefs, October 2007
Snippets about Globespan, New Leaf, Zone, Draper Fisher Jurvetson, Glenmont, MSBI, Craton, Claritas and BCE.